5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated Kinase

Stem Cells and Development

Volumn 21, Issue 1, 2012, Pages 67-75

  Qian, Qian ^a   Qian, Hui ^a   Zhang, Xu ^a   Zhu, Wei ^a   Yan, Yongmin ^a   Ye, Shengqin ^b   Peng, Xiujuan ^a   Li, Wei ^b   Xu, Zhe ^a   Sun, Lingyun ^c   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

^b China Medical City   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ATRIAL NATRIURETIC FACTOR; AZACITIDINE; BINDING PROTEIN; DESMIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYOCYTE ENHANCER BINDING FACTOR 2C; MYOD PROTEIN; MYOSIN HEAVY CHAIN BETA; PROTEIN KINASE C; STAT3 PROTEIN; TRANSCRIPTION FACTOR NKX2.5; TROPONIN T; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DIPLOIDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MESENCHYMAL STEM CELL; MYOFILAMENT; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL CORD; UPREGULATION;

ANTIGENS, DIFFERENTIATION; AZACITIDINE; BUTADIENES; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; ENZYME ACTIVATORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HUMANS; MADS DOMAIN PROTEINS; MESENCHYMAL STEM CELLS; MUSCLE PROTEINS; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS; NITRILES; PHOSPHORYLATION; STAT3 TRANSCRIPTION FACTOR; UMBILICAL CORD;

EID: 84855446143     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0519     Document Type: Article

References (35)

1. Hare JM and SV Chaparro. 2008). Cardiac regeneration and stem cell therapy. Curr Opin Organ Transplant 13:536-542.
2. Miyahara Y, N Nagaya, M Kataoka, B Yanagawa, K Tanaka, H Hao, K Ishino, H Ishida, T Shimizu, K Kangawa, S Sano, T Okano, S Kitamura and H Mori. 2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12:459-465.
3. Obradović S, S Rusović, B Balint, A Ristić-Andelkov, R Romanovic ́, B Baskot, D Vojvodić and B Gligić. 2004). Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction. Vojnosanit Pregl 61:519-529.
4. Makino S, K Fukuda, S Miyoshi, F Konishi, H Kodama, J Pan, M Sano, T Takahashi, S Hori, H Abe, J Hata, A Umezawa and S Ogawa. 1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705. (Pubitemid 29122423)
5. Moscoso I, A Centeno, E Ló pez, JI Rodriguez-Barbosa, I Santamarina, P Filgueira, MJ Sánchez, R Domínguez-Perles, G Peñ uelas-Rivas and N Domenech. 2005). Differentiation in vitro of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. Transplant Proc 37:481-482. (Pubitemid 40459824)
6. Xu W, X Zhang, H Qian, W Zhu, X Sun, J Hu, H Zhou and Y Chen. 2004). Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 229:623-631. (Pubitemid 38878907)
7. Qiao C, W Xu, W Zhu, J Hu, H Qian, Q Yin, R Jiang, Y Yan, F Mao, H Yang, X Wang and Y Chen. 2008). Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 32:8-15. (Pubitemid 351255581)
8. Kestendjieva S, D Kyurkchiev, G Tsvetkova, T Mehandjiev, A Dimitrov, A Nikolov and S Kyurkchiev. 2008). Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int 32:724-732.
9. Yan Y, W Xu, H Qian, Y Si, W Zhu, H Cao, H Zhou and F Mao. 2009). Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int 29:356-365.
10. Chen Y, H Qian,WZhu, X Zhang, Y Yan, S Ye, X Peng,WLi and W Xu. 2010). Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev 20:103-113.
11. Cao H, H Qian,WXu,WZhu, X Zhang, Y Chen, M Wang, Y Yan and Y Xie. 2010). Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/ reperfusion-induced acute renal failure in rats. Biotechnol Lett 32:725-732.
12. Cho J, P Rameshwar and J Sadoshima. 2009). Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3b in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. J Biol Chem 284: 36647-36658.
13. Yao Y, W Li, J Wu, UA Germann, MS Su, K Kuida and DM Boucher. 2003). Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci USA 100:12759-12764. (Pubitemid 37339972)
14. Jaiswal RK, N Jaiswal, SP Bruder, G Mbalaviele, DR Marshak and MF Pittenger. 2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645-9652. (Pubitemid 30185197)
15. Sale EM, PG Atkinson and GJ Sale. 1995). Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 14:674-684.
16. Kim HS, JW Cho, K Hidaka and T Morisaki. 2007). Activation of MEK-ERK by heregulin-b1 promotes the development of cardiomyocytes derived from ES cells. Biochem Biophys Res Commun 361:732-738. (Pubitemid 47238023)
17. Fukuda K. 2003). Regeneration of cardiomyocytes from bone marrow: use of mesenchymal stem cell for cardiovascular tissue engineering. Cytotechnology 41:165-175. (Pubitemid 37045956)
18. Wu KH, XM Mo, B Zhou, SH Lu, SG Yang, YL Liu and ZC Han. 2009). Cardiac potential of stem cells from whole human umbilical cord tissue. J Cell Biochem 107:926-932.
19. Wang HS, SC Hung, ST Peng, CC Huang, HM Wei, YJ Guo, YS Fu, MC Lai and CC Chen. 2004). Mesenchymal stem cells in the Wharton s jelly of the human umbilical cord. Stem Cells 22:1330-1337.
20. Weiss ML, S Medicetty, AR Bledsoe, RS Rachakatla, M Choi, S Merchav, Y Luo, MS Rao, G Velagaleti and D Troyer. 2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson s disease. Stem Cells 24:781-792. (Pubitemid 44464783)
21. Panepucci RA, JL Siufi, WA Silva Jr, R Proto-Siquiera, L Neder, M Orellana, V Rocha, DT Covas and MA Zago. 2004). Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22:1263-1278. (Pubitemid 39646504)
22. Kadivar M, S Khatami, Y Mortazavi, MA Shokrgozar, M Taghikhani and M Soleimani. 2006). In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 340:639-647. (Pubitemid 43021794)
23. Liu Y, J Song, W Liu, Y Wan, X Chen and C Hu. 2003). Growth and differentiation of rat bone marrow stromal cells: Does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovasc Res 58:460-468. (Pubitemid 36570404)
24. Chiu CP and HM Blau. 1985). 5-Azacytidine permits gene activation in a previously noninducible cell type. Cell 40: 417-424. (Pubitemid 15138468)
25. Taylor SM and PA Jones. 1979). Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779. (Pubitemid 9252286)
26. Capiati DA, F Limbozzi, MT Téllez-Iñ ón and RL Boland. 1999). Evidence on the participation of protein kinase C alpha in the proliferation of cultured myoblasts. J Cell Biochem 74:292-300. (Pubitemid 29307717)
27. Shaul YD and R Seger. 2007). The MEK/ERK cascade: From signaling specificity to diverse functions. Biochim Bio phys Acta 1773:1213-1226. (Pubitemid 47125968)
28. Tortorella LL, DJ Milasincic and PF Pilch. 2001). Critical proliferation independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J Biol Chem 276:13709-13717.
29. Hirano T, K Ishihara and M Hibi. 2000). Roles of STAT3 in mediating the cell growth,differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19:2548-2556. (Pubitemid 30339210)
30. Chung J, E Uchida, TC Grammer and J Blenis. 1997). STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17:6508-6516. (Pubitemid 27451197)
31. Haq R, A Halupa, BK Beattie, JM Mason, BW Zanke and DL Barber. 2002). Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases. J Biol Chem 277:17359-17366. (Pubitemid 34967772)
32. Yang Y, Y Xu,WLi, GWang, Y Song, G Yang, X Han, Z Du, L Sun and K Ma. 2009). STAT3 induces muscle stem cell differentiation by interaction with myoD. Cytokine 46:137-141.
33. Harvey RP. 1999). Seeking a regulatory roadmap for heart morphogenesis. Semin Cell Dev Biol 10:99-107. (Pubitemid 129505543)
34. Molkentin JD, BL Black, JF Martin and EN Olson. 1995). Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136. (Pubitemid 26007804)
35. Black BL and EN Olson. 1998). Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14:167-196. (Pubitemid 29001453)